Clinical Trials
4 trialsNCT04552327 2024-03-05
KOHDIAK
Infectopharm Arzneimittel GmbH
Phase 3 Completed
NCT01962987 2020-07-20
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
Actavis Inc.
Phase 3 Completed
NCT03826550 2019-02-01
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
Encube Ethicals Pvt. Ltd.
Phase 3 Completed
NCT02611804 2017-05-05
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
Teva Pharmaceuticals USA
Phase 3 Completed